Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model

Clinical and Vaccine Immunology

Volumn 17, Issue 11, 2010, Pages 1666-1671

  Islam, Anjum ^a   Raghupathy, Raj ^a   Albert, M John ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PORIN A; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; FECES ANALYSIS; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCREENING; SEROTYPE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL VACCINES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CROSS PROTECTION; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; GASTROINTESTINAL TRACT; INTESTINES; MICE; MICE, INBRED BALB C; PORINS; SERUM; VACCINES, SYNTHETIC;

EID: 78449244388     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00255-10     Document Type: Article

References (45)

1. Albert, M. J., S. Haridas, and B. Adler. 2008. Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin. Clin. Vaccine Immunol. 15:859-862.
2. Albert, M. J., E. Udo, B. T. Jose, S. Haridas, and V. O. Rotimi. 2009. Tetracycline resistance is frequent among Campylobacter jejuni isolates from Kuwait. Microb. Drug Res. 15:115-120.
3. Anosova, N. G., S. Chabot, V. Shreedhar, J. A. Borawski, B. L. Dickinson, and M. R. Neutra. 2008. Cholera toxin, Escherichia coli heat-labile toxin, and non-toxic derivatives induce cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol. 1:59-67.
4. Baqar, S., L. A. Applebee, T. C. Gilliland, Jr., L. H. Lee, C. K. Porter, and P. Guerry. 2008. Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice. Infect. Immun. 76:3170-3175.
5. Baqar, S., A. L. Bourgeois, L. A. Applebee, A. S. Mourad, M. T. Kleinosky, Z. Mohran, and J. R. Murphy. 1996. Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity. Infect. Immun. 64:4933-4939.
6. Baqar, S., A. L. Bourgeois, P. J. Schultheiss, R. I. Walker, D. M. Rollins, R. L. Haberberger, and O. R. Pavlovskis. 1995. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine 13:22-28.
7. Baqar, S., N. D. Pacheco, and F. M. Rollwagen. 1993. Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob. Agents Chemother. 37:2688-2692.
8. Blaser, M. J., and D. J. Duncan. 1984. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect. Immun. 44:292-298.
9. Blaser, M. J., D. J. Duncan, G. H. Warren, and W. L. Wang. 1983. Experimental Campylobacter jejuni infection of adult mice. Infect. Immun. 39:908-916.
10. Blaser, M. J., and J. Engberg. 2008. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections, p. 99-121. In I. Nachamkin, C. M. Szymanski, and M. J. Blaser (ed.), Campylobacter, 3rd ed. ASM Press, Washington, DC.
11. Blaser, M. J., J. A. Hopkins, R. M. Berka, M. L. Vasil, and W. L. Wang. 1983. Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect. Immun. 42:276-284.
12. Blaser, M. J., J. A. Hopkins, and M. L. Vasil. 1984. Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect. Immun. 43:986-993.
13. Burr, D. H., M. B. Caldwell, A. L. Bourgeois, H. R. Morgan, R. Wistar, Jr., and R. I. Walker. 1988. Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation. Infect. Immun. 56:99-105.
14. Cawthraw, S. A., T. M. Wassenaar, R. Ayling, and D. G. Newell. 1996. Increased colonization potential of Campylobacter jejuni strain 81116 after passage through chickens and its implication on the rate of transmission within flocks. Epidemiol. Infect. 117:213-215.
15. Chong, C., M. Friberg, and J. D. Clements. 1998. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16:732-740.
16. Clark, C. G., A. Beeston, L. Bryden, G. Wang, C. Barton, W. Cuff, M. W. Gilmour, and L. K. Ng. 2007. Phylogenetic relationships of Campylobacter jejuni based on porA sequences. Can. J. Microbiol. 53:27-38.
17. Cody, A. J., M. J. C. Maiden, and K. E. Dingle. 2009. Genetic diversity and stability of the porA allele as a genetic marker in human Campylobacter infection. Microbiology 155:4145-4154.
18. Coker, A. O., R. D. Isokpehi, B. N. Thomas, K. O. Amisu, and C. L. Obi. 2002. Human campylobacteriosis in developing countries. Emerg. Infect. Dis. 8:237-243.
19. Friedman, C. R., J. Neimann, H. C. Wegener, and R. V. Tauxe. 2000. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations, p. 121-138. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. ASM Press, Washington, DC.
20. Guerrant, R. L., C. A. Wanke, R. A. Pennie, L. J. Barrett, A. A. Lima, and A. D. O'Brien. 1987. Production of a unique cytotoxin by Campylobacter jejuni. Infect. Immun. 55:2526-2530.
21. Huang, S., O. Sahin, and Q. Zhang. 2007. Infection-induced antibodies against the major outer membrane protein of Campylobacter jejuni mainly recognize conformational epitopes. FEMS Microbiol. Lett. 272:137-143.
22. Hughes, E. E., and H. E. Gilleland, Jr. 1995. Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia model. Vaccine 13:1750-1753.
23. Jagusztyn-Krynicka, E. K., P. Laniewski, and A. Wyszynska. 2009. Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. Expert Rev. Vaccines 8:625-645.
24. Jones, M. A., K. L. Marston, C. A. Woodall, D. J. Maskell, D. Linton, A. V. Karlyshev, N. Dorrell, B. W. Wren, and P. A. Barrow. 2004. Adaptation of Campylobacter jejuni NCTC11168 to high-level colonization of the avian gastrointestinal tract. Infect. Immun. 72:3769-3776.
25. Karlyshev, A. V., D. Linton, N. A. Gregson, A. J. Lastovica, and B. W. Wren. 2000. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol. Microbiol. 35:529-541.
26. Khan, I., B. Adler, S. Haridas, and M. J. Albert. 2005. PorA protein of Campylobacter jejuni is not a cytotoxin mediating inflammatory diarrhoea. Microbes Infect. 7:853-859.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
28. Lee, L. H., E. Burg III, S. Baqar, A. L. Bourgeois, D. H. Burr, C. P. Ewing, T. J. Trust, and P. Guerry. 1999. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect. Immun. 67:5799-5805.
29. Monteiro, M. A., S. Baqar, E. R. Hall, Y. H. Chen, C. K. Porter, D. E. Bentzel, L. Applebee, and P. Guerry. 2009. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect. Immun. 77:1128-1136.
30. Moser, I., W. Schroeder, and J. Salnikow. 1997. Campylobacter jejuni major outer membrane protein and a 59-kDa protein are involved in binding to fibronectin and INT 407 cell membranes. FEMS Microbiol. Lett. 157:233-238.
31. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken. 1999. Manual of clinical microbiology, 7th ed. ASM Press, Washington, DC.
32. Nachamkin, I., X. H. Yang, and N. J. Stern. 1993. Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants. Appl. Environ. Microbiol. 59:1269-1273.
33. Newell, D. G., M. Koopmans, L. Verhoef, E. Duizer, A. Aidara-Kane, H. Sprong, M. Opsteegh, M. Langelaar, J. Threfall, F. Scheutz, J. van der Giessen, and H. Kruse. 2010. Food-borne diseases-The challenge of 20 years ago still persist while new ones continue to emerge. Int. J. Food Microbiol. 139(Suppl.):S3-S15.
34. Oberhelman, R. A., and D. N. Taylor. 2000. Campylobacter infections in developing countries, p. 139-154. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. ASM Press, Washington, DC.
35. Panigrahi, P., G. Losonsky, L. J. DeTolla, and J. G. Morris, Jr. 1992. Human immune response to Campylobacter jejuni proteins expressed in vivo. Infect. Immun. 60:4938-4944.
36. Pavlovskis, O. R., D. M. Rollins, R. L. Haberberger, Jr., A. E. Green, L. Habash, S. Strocko, and R. I. Walker. 1991. Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp. Infect. Immun. 59:2259-2264.
37. Peterson, M. C. 1994. Clinical aspects of Campylobacter jejuni infections in adults. West. J. Med. 161:148-152.
38. Prokhorova, T. A., P. N. Nielsen, J. Petersen, T. Kofoed, J. S. Crawford, C. Morsczeck, A. Boysen, and P. Schrotz-King. 2006. Novel surface polypeptides of Campylobacter jejuni as traveller's diarrhoea vaccine candidates discovered by proteomics. Vaccine 24:6446-6455.
39. Ringoir, D. D., and V. Korolik. 2003. Colonization phenotype and colonization potential differences in Campylobacter jejuni strains in chickens before and after passage in vivo. Vet. Microbiol. 92:225-235.
40. Ryan, E. J., E. McNeela, M. Pizza, R. Rappouli, L. O'Neill, and K. H. G. Mills. 2000. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and enzyme activity. J. Immunol. 165:5750-5759.
41. Schroder, W., and I. Moser. 1997. Primary structure analysis and adhesion studies on the major outer membrane protein of Campylobacter jejuni. FEMS Microbiol. Lett. 150:141-147. (Pubitemid 27234425)
42. Sizemore, D. R., B. Warner, J. Lawrence, A. Jones, and K. P. Killeen. 2006. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens. Vaccine 24:3793-3803.
43. Taha, M. K., M. L. Zarantonelli, J. M. Alonso, L. M. Naess, J. Holst, B. Feiring, and E. Rosenqvist. 2007. Use of available outer membrane vesicles to control serogroup B meningococcal outbreaks. Vaccine 25:2537-2538.
44. Zhang, Q., J. C. Meitzler, S. Huang, and T. Morishita. 2000. Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein. Infect. Immun. 68:5679-5689.
45. Zhang, Y. X., S. Stewart, T. Joseph, H. R. Taylor, and H. D. Caldwell. 1987. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J. Immunol. 138:575-581.